Peptide therapy has low toxicity, high potency, and high specificity for treating a wide range of health issues
For GLP-1 Receptor Agonists, research is overwhelmingly concentrated on: Metabolic Disease: The cornerstone of GLP-1 research is its effect on blood glucose, insulin sensitivity, and HbA1c levels in models of type 2 diabetes
Ubiquitin C-terminal hydrolase-l1 activity induces polyubiquitin accumulation in podocytes and increases proteinuria in rat membranous nephropathy
Researchers using these peptides should understand they are working with promising but preliminary evidence, not settled science
Media interested in setting up an interview with a representative from Kyowa Hakko to discuss the health benefits of glutathione, please contact Sara White: [email protected], 212-693-2150
Feb 15 2004;103(4):1364-1369